1. 1213. A TRAIL/IP-10/CRP Signature Distinguishes between Viral and Bacterial Infection in Chronic Obstructive Pulmonary Disease Patients. (31st December 2020) Authors: Paz, Meital; Halabi, Salim; Shiber, Shachaf; Neuberger, Ami; Petersiel, Neta; Grupper, Mordechai; Kirshner, Dani; Avni, Noa; Stein, Michal; Kronenfeld, Gali; Shani, Liran; Gottlieb, Tanya; Lishtzinsky, Ynon; Maor, Yasmin; Yanai, Shirly; Oved, Kfir; Eden, Eran; Drescher, Michael; Paul, Michal Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1348. A Novel Host-Protein Signature Comprising TRAIL, IP-10 and CRP Differentiates Bacterial from Viral Infection in COPD Patients with Suspected Lower Respiratory Tract Infection. (4th December 2021) Authors: Halabi, Salim; Shiber, Shachaf; Stein, Michal; Paz, Meital; Gottlieb, Tanya; Barash, Eran; Navon, Roy; Moscoviz, Einat; Ber, Tahel Ilan; Shani, Liran; Petersiel, Neta; Boico, Olga; Grupper, Mordechai; Simon, Einav; Kirshner, Dani; Avni, Noa; Haber, Daniel; Maor, Yasmin; Guetta, Claire S; Lishtzin... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 651: CEFTOLOZANE/TAZOBACTAM AND CEFTAZIDIME/AVIBACTAM AGAINST MEROPENEM-RESISTANT PSEUDOMONAS AERUGINOSA. Issue 12 (December 2016) Authors: Grupper, Mordechai; Sutherland, Christina; Nicolau, David Journal: Critical care medicine Issue: Volume 44:Issue 12(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery system. Issue 1 (December 2017) Authors: Ghazi, Islam; Grupper, Mordechai; Nicolau, David Journal: Annals of clinical microbiology and antimicrobials Issue: Volume 16:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antibacterial activity of human simulated epithelial lining fluid concentrations of amikacin inhale alone and in combination with meropenem against Acinetobacter baumannii. Issue 11 (2nd December 2017) Authors: Ghazi, Islam M.; Grupper, Mordechai; Nicolau, David P. Journal: Infectious diseases Issue: Volume 49:Issue 11/12(2017:Nov.) Page Start: 831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Obesity and skin and soft tissue infections: how to optimize antimicrobial usage for prevention and treatment?. Issue 2 (April 2017) Authors: Grupper, Mordechai; Nicolau, David P. Journal: Current opinion in infectious diseases Issue: Volume 30:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery. (7th December 2016) Authors: Grupper, Mordechai; Kuti, Joseph L.; Swank, Morgan L.; Maggio, Lindsay; Hughes, Brenna L.; Nicolau, David P. Journal: Journal of clinical pharmacology Issue: Volume 57:Number 6(2017) Page Start: 712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function. (December 2017) Authors: Thabit, Abrar K.; Grupper, Mordechai; Nicolau, David P.; Kuti, Joseph L. Other Names: Millares-Sipin Catherine A. guest-editor. Journal: Journal of pharmacy practice Issue: Volume 30:Number 6(2017:Dec.) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The Effect of Clinical Concentrations of Meropenem (MEM), Ceftolozane/tazobactam (C/T), and Ceftazidime/avaibactam (CZA) on Time to Detection (TTD) and Growth of Pseudomonas aeruginosa (PSA) in bioMerieux BacT/ALERT®FA Plus Blood Culture (BC) Bottles. (4th October 2017) Authors: Grupper, Mordechai; Nicolau, David P; Tanner, Linda; Kuti, Joseph L Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗